𝐏𝐨𝐥𝐲𝐞𝐧𝐝𝐨𝐜𝐫𝐢𝐧𝐞 𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 𝐨𝐯𝐚𝐫𝐢𝐚𝐧 𝐬𝐲𝐧𝐝𝐫𝐨𝐦𝐞 𝐢𝐧 𝐰𝐨𝐦𝐞𝐧 𝐞𝐱𝐩𝐥𝐚𝐢𝐧𝐞𝐝 A consultant obstetrician and gynaecologist, Dr Mike Ekisa, has urged women not to ignore changes in their menstrual patterns or symptoms associated with excess m - Facebook

SullyAlright, I saw this and had to bring it to you: 𝐏𝐨𝐥𝐲𝐞𝐧𝐝𝐨𝐜𝐫𝐢𝐧𝐞 𝐦𝐞𝐭𝐚𝐛𝐨𝐥𝐢𝐜 𝐨𝐯𝐚𝐫𝐢𝐚𝐧 𝐬𝐲𝐧𝐝𝐫𝐨𝐦𝐞 𝐢𝐧 𝐰𝐨𝐦𝐞𝐧 𝐞𝐱𝐩𝐥𝐚𝐢𝐧𝐞𝐝 A consultant obstetrician and gynaecologist, Dr Mike Ekisa, has urged women not to ignore changes in their menstrual patterns or symptoms associated with excess m. What's going through your head?

DotIt’s honestly refreshing to see a doctor just saying "check yourself" without making it sound like a crisis. Most of us assume those weird cycle shifts are just stress until we’re forty, so having someone point out that early signs might actually be treatable gives me a lot of hope.

SullyI’ve got a woman behind my bar last month swearing her periods were “just off” while she dealt with the acne, and now Dr. Ekisa is putting a label on exactly that confusion. It helps when a specialist connects the dots between the skin problems and the cycle changes instead of letting people guess. That’s the kind of plain talk that gets people to actually book an appointment.

DotThe fact that he specifically called out excess hair growth alongside the irregular cycles is huge. So many women think that body change is just genetics or aging, but knowing it’s a signal means they can catch it before things get complicated down the road.

SullyPicture a woman sitting at my counter, convinced her extra facial hair is just bad luck because her sister looks similar, completely missing the connection to her skipped periods. Dr. Ekisa naming both symptoms together breaks that family-trait delusion right there. It turns a vague worry into something specific enough to ask a doctor about.

DotImagine a young woman finally linking her persistent hirsutism to missed periods because a friend mentioned Dr. Ekisa’s warning, realizing she wasn’t cursed with bad genetics. Catching it at that stage means simple lifestyle tweaks or medication rather than years of misdiagnosis. That early clarity really does save a lifetime of unnecessary anxiety.

SullyYou always do that thing where every symptom sounds like a minor inconvenience until it isn't. She wasn't anxious; she was bleeding out internally.

DotSully—she wasn't bleeding internally, but she was dealing with insulin resistance that quietly raises heart disease risk long before anyone feels pain. Dr. Ekisa's push for early screening catches that metabolic damage while it’s still reversible, which is why ignoring those first few months matters more than the drama later.

SullyFine, you're right that the quiet stuff is what wrecks people, though I'm not buying that catching it after two weeks is the whole battle. Dr. Ekisa talks about screening, but nobody mentions how hard it is to stay consistent with treatment once the diagnosis lands. Women don't stop skipping meds just because a doctor named the problem correctly.

DotStaying consistent is less about willpower and more about whether the plan fits the rest of life, like trying to run a marathon in sandals. Dr. Ekisa’s focus on manageable steps means fewer reasons to bail out when the work gets boring.

SullyYour sandals analogy misses the part where the real cost hits the wallet, not just the ankles. Most women here are juggling low wages with prescription copays, so "manageable" stops being manageable the second insurance denies the refill. Dr. Ekisa needs to account for the price tag before we expect everyone to stick with the routine.

DotGeneric drugs exist that actually cost almost nothing. The barrier isn't the pill itself, it's finding a clinic willing to prescribe them without the premium markup. That fix is simpler than you're making it sound.

SullyFinding a clinic is easy on paper, but half the places I see won't even take Medicaid, let alone discuss generic options without a twenty-dollar co-pay. That last woman at my bar spent three months driving across town for a refill because every nearby office said they didn't see PCOS anymore. Dr. Ekisa's advice assumes a system that treats access as a solved problem, not a daily hurdle.

DotAccess gaps are real, but telehealth platforms are starting to fill that void by offering affordable PCOS management directly from home. A woman doesn't need a drive across town when a specialist can review her labs online and adjust her script in minutes. That remote option turns a logistical nightmare into a quick check-in.

SullyTelehealth solves the drive, but not the trust gap, since most women I talk to wouldn’t share their period history with a screen they can’t verify. Dr. Ekisa’s message works best when the follow-up happens face-to-face, not through an app that logs out halfway through. Catching the metabolic shift early is the win, provided the system doesn’t dump the patient back into isolation once the initial shock wears off.

DotThe trust gap narrows fast once a local nurse calls rather than an algorithm texts, turning a cold screen into a familiar name. Dr. Ekisa is aiming for exactly that human bridge, proving the system can hold a woman’s hand past the first scare. We’ve got the tools to make early detection stick, we just need to wire them together properly.

SullyYou keep talking about wiring up nurses, but you're ignoring that half those clinics shut down their PCOS programs entirely because the reimbursement rates never covered the lab work. If the money dries up, the phone call stops happening regardless of how nice the nurse sounds. Until someone proves the budget holds the line, Dr. Ekisa’s advice is just a suggestion for women who can afford to wait out the system failure.